​

Gilead Sciences Ownership | Who Owns Gilead Sciences?

OverviewForecastRevenueFinancialsChartTranscripts

Gilead Sciences Ownership Summary

Gilead Sciences is owned by 47.97% institutional investors, 0.11% insiders, and 51.92% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 9.92% of GILD shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.17% of its assets in Gilead Sciences shares.

GILD Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockGilead Sciences47.97%0.11%51.92%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryDrug Manufacturers - General Stocks26.93%1.98%71.09%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de123.20M9.92%$15.12B
Vanguard group121.10M9.74%$14.86B
Blackrock120.63M9.67%$8.28B
Fmr60.32M4.84%$6.70B
State street59.09M4.75%$6.56B
Capital world investors42.87M3.45%$5.26B
Dodge & cox30.13M2.42%$3.34B
Geode capital management29.70M2.39%$3.64B
Price t rowe associates inc /md/26.50M2.13%$2.94B
Wellington management group llp25.62M2.06%$2.84B

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Mccarthy asset management130.36K5.27%$8.94M
Sector gamma as176.41K4.94%$21.65M
Nexus investment management ulc257.82K4.31%$31.65M
Opes wealth management169.65K3.40%$20.82M
Kiltearn partners llp145.80K3.24%$16.18M
Twin lakes capital management58.75K3.20%$7.21M
Old north state wealth management50.38K2.91%$6.19M
Polaris capital management265.10K2.70%$32.54M
Alphacentric advisors21.76K2.66%$2.67M
Brookmont capital management36.59K2.60%$4.49M

Top Buyers

HolderShares% AssetsChange
Norges bank21.32M0.28%21.32M
Blackrock funding, inc. /de123.20M0.26%6.91M
Massachusetts financial services co /ma/4.22M0.17%4.11M
Barclays9.12M0.27%3.94M
Price t rowe associates inc /md/26.50M0.31%2.92M

Top Sellers

HolderShares% AssetsChange
Wellington management group llp25.62M0.50%-11.91M
Citadel advisors278.39K0.00%-5.04M
Capital research global investors25.31M0.57%-4.71M
Pacer advisors---3.59M
Assenagon asset management267.05K0.05%-3.22M

New Positions

HolderShares% AssetsChangeValue
Norges bank21.32M0.28%21.32M$2.62B
Axa investment managers1.66M0.50%1.66M$184.10M
Alecta tjanstepension omsesidigt814.33K0.44%814.33K$99.95M
Masters capital management385.00K1.49%385.00K$26.41M
Capitolis liquid global markets364.00K0.32%364.00K$40.40M

Sold Out

HolderChange
Hoey investments-2.00
Mendota financial group-3.00
Breakwater investment management-4.00
Cypress capital management llc (wy)-5.00
New millennium group-7.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20251,572-24.82%596,256,840-43.48%470.67%840-15.07%515-28.57%
Sep 30, 20251,457-29.51%484,334,760-52.85%380.57%702-30.56%504-30.86%
Jun 30, 20252,053-0.73%1,072,004,9014.47%861.27%1,0044.26%720-12.41%
Mar 31, 202519-99.01%5,280,450-99.50%-0.01%7-99.24%5-99.30%
Dec 31, 20241,238-29.82%522,772,791-49.04%410.62%590-25.69%468-31.68%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF39.45M3.17%28.77K
Vanguard Total Stock Mkt Idx Inv39.08M3.15%83.58K
Vanguard Institutional 500 Index Trust35.44M2.85%245.78K
Vanguard 500 Index Investor31.61M2.55%197.14K
Invesco QQQ Trust26.55M2.14%-58.84K
American Funds Income Fund of Amer A19.62M1.58%-
Dodge & Cox Stock I19.51M1.57%-3.12M
iShares Core S&P 500 ETF15.80M1.27%2.86M
Fidelity 500 Index15.69M1.26%19.88K
SPDR® S&P 500 ETF15.51M1.25%-227.69K

Recent Insider Transactions

DateNameRoleActivityValue
Feb 27, 2026O'Day Daniel Patrick Chairman & CEOSell$14.57K
Feb 27, 2026O'Day Daniel Patrick Chairman & CEOSell$501.39K
Feb 27, 2026O'Day Daniel Patrick Chairman & CEOSell$931.90K
Feb 17, 2026Mercier Johanna Chief Comm & Corp Aff OfficerSell$2.84M
Feb 17, 2026Mercier Johanna Chief Comm & Corp Aff OfficerSell$1.46M

Insider Transactions Trends

DateBuySell
2026 Q1-14
2025 Q4-18
2025 Q3-16
2025 Q2-11
2025 Q1-7

GILD Ownership FAQ

Who Owns Gilead Sciences?

Gilead Sciences shareholders are primarily institutional investors at 47.97%, followed by 0.11% insiders and 51.92% retail investors. The average institutional ownership in Gilead Sciences's industry, Drug Manufacturers - General Stocks, is 26.93%, which Gilead Sciences exceeds.

Who owns the most shares of Gilead Sciences?

Gilead Sciences’s largest shareholders are Blackrock funding, inc. /de (123.2M shares, 9.92%), Vanguard group (121.1M shares, 9.74%), and Blackrock (120.63M shares, 9.67%). Together, they hold 29.34% of Gilead Sciences’s total shares outstanding.

Does Blackrock own Gilead Sciences?

Yes, BlackRock owns 9.67% of Gilead Sciences, totaling 120.63M shares as of Jun 2024. This represents 0.19% of BlackRock's total assets, with a market value of 8.28B$. In the last quarter, BlackRock decreased its holdings by -1.899M shares, a -1.55% change.

Who is Gilead Sciences’s biggest shareholder by percentage of total assets invested?

Mccarthy asset management is Gilead Sciences’s biggest shareholder by percentage of total assets invested, with 5.27% of its assets in 130.36K Gilead Sciences shares, valued at 8.94M$.

Who is the top mutual fund holder of Gilead Sciences shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Gilead Sciences shares, with 3.17% of its total shares outstanding invested in 39.45M Gilead Sciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools